Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer
Version of Record online: 5 NOV 2012
Copyright © 2012 Wiley Periodicals, Inc.
Volume 73, Issue 6, pages 657–667, May 2013
How to Cite
Nordin, A., Wang, W., Welén, K. and Damber, J.-E. (2013), Midkine is associated with neuroendocrine differentiation in castration-resistant prostate cancer. Prostate, 73: 657–667. doi: 10.1002/pros.22607
- Issue online: 4 APR 2013
- Version of Record online: 5 NOV 2012
- Manuscript Accepted: 5 OCT 2012
- Manuscript Received: 19 JUN 2012
- Swedish Cancer Society. Grant Number: CAN2009/33
- ALF/Västra Götalandsregionen. Grant Number: ALFGBG-138351
- Proliv Väst and the Royal and Hvitfeldska Foundation
- Urological Clinic, Sahlgrenska University Hospital, Assar Gabrielsson. Grant Numbers: FB 09-72, FB 10-83
- Sahlgrenska University Hospital
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.